Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Total Valuation

PEX:JPH has a market cap or net worth of JOD 49.12 million. The enterprise value is 40.44 million.

Market Cap	49.12M
Enterprise Value	40.44M

Important Dates

The next estimated earnings date is Sunday, August 10, 2025.

Earnings Date	Aug 10, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

PEX:JPH has 18.00 million shares outstanding.

Current Share Class	18.00M
Shares Outstanding	18.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	42.26%
Owned by Institutions (%)	5.95%
Float	6.90M

Valuation Ratios

The trailing PE ratio is 10.09.

PE Ratio	10.09
Forward PE	n/a
PS Ratio	1.65
PB Ratio	0.94
P/TBV Ratio	0.98
P/FCF Ratio	5.20
P/OCF Ratio	4.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.90, with an EV/FCF ratio of 4.28.

EV / Earnings	8.31
EV / Sales	1.36
EV / EBITDA	5.90
EV / EBIT	7.06
EV / FCF	4.28

Financial Position

The company has a current ratio of 4.37, with a Debt / Equity ratio of 0.01.

Current Ratio	4.37
Quick Ratio	3.42
Debt / Equity	0.01
Debt / EBITDA	0.08
Debt / FCF	0.06
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 9.74% and return on invested capital (ROIC) is 6.99%.

Return on Equity (ROE)	9.74%
Return on Assets (ROA)	5.77%
Return on Invested Capital (ROIC)	6.99%
Return on Capital Employed (ROCE)	10.18%
Revenue Per Employee	55,910
Profits Per Employee	9,164
Employee Count	531
Asset Turnover	0.48
Inventory Turnover	2.16

Taxes

In the past 12 months, PEX:JPH has paid 1.33 million in taxes.

Income Tax	1.33M
Effective Tax Rate	21.48%

Stock Price Statistics

The stock price has increased by +5.48% in the last 52 weeks. The beta is 0.12, so PEX:JPH's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	+5.48%
50-Day Moving Average	3.73
200-Day Moving Average	3.69
Relative Strength Index (RSI)	55.15
Average Volume (20 Days)	4,257

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PEX:JPH had revenue of JOD 29.69 million and earned 4.87 million in profits. Earnings per share was 0.27.

Revenue	29.69M
Gross Profit	15.35M
Operating Income	5.73M
Pretax Income	6.20M
Net Income	4.87M
EBITDA	6.62M
EBIT	5.73M
Earnings Per Share (EPS)	0.27

Balance Sheet

The company has 9.96 million in cash and 555,744 in debt, giving a net cash position of 9.40 million or 0.52 per share.

Cash & Cash Equivalents	9.96M
Total Debt	555,744
Net Cash	9.40M
Net Cash Per Share	0.52
Equity (Book Value)	52.15M
Book Value Per Share	2.86
Working Capital	27.99M

Cash Flow

In the last 12 months, operating cash flow was 11.20 million and capital expenditures -1.75 million, giving a free cash flow of 9.44 million.

Operating Cash Flow	11.20M
Capital Expenditures	-1.75M
Free Cash Flow	9.44M
FCF Per Share	0.52

Margins

Gross margin is 51.72%, with operating and profit margins of 19.30% and 16.39%.

Gross Margin	51.72%
Operating Margin	19.30%
Pretax Margin	20.89%
Profit Margin	16.39%
EBITDA Margin	22.31%
EBIT Margin	19.30%
FCF Margin	31.81%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 2.08%.

Dividend Per Share	0.06
Dividend Yield	2.08%
Dividend Growth (YoY)	-19.95%
Years of Dividend Growth	n/a
Payout Ratio	24.44%
Buyback Yield	n/a
Shareholder Yield	2.08%
Earnings Yield	9.91%
FCF Yield	19.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 1, 2013. It was a forward split with a ratio of 1.4216864044.

Last Split Date	Aug 1, 2013
Split Type	Forward
Split Ratio	1.4216864044

Scores

PEX:JPH has an Altman Z-Score of 4.25 and a Piotroski F-Score of 5.

Altman Z-Score	4.25
Piotroski F-Score	5